JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AC
5976
DELISTED
Associated Capital Group
AC
| $24.2K | ﹤0.01% |
706
+3
| +0.4% | +$109 |
2023 Q3
5 quarters
|
|
5977
Cibus
CBUS
$125M
| $23.7K | ﹤0.01% |
8,534
-6,818
| -44% | -$26.4K |
2023 Q1
7 quarters
|
|
5978
CI&T Inc
CINT
$402M
| $23.7K | ﹤0.01% |
+3,900
| New | +$26.3K |
2024 Q4
0 quarters
|
|
|
GSWO
5979
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.78B
| $23.6K | ﹤0.01% |
478
+71
| +17% | +$3.6K |
2024 Q3
1 quarter
|
|
|
HEPS
5980
D-Market Electronic Services & Trading
HEPS
$886M
| $23.5K | ﹤0.01% |
7,755
-88,025
| -92% | -$262K |
2024 Q2
2 quarters
|
|
|
AISP
5981
Airship AI Holdings
AISP
$76.5M
| $23.4K | ﹤0.01% |
3,743
-23,668
| -86% | -$69.6K |
2024 Q1
3 quarters
|
|
5982
Gladstone Investment Corp
GAIN
$627M
| $23.3K | ﹤0.01% |
1,761
+1,724
| +4,659% | +$23.5K |
2024 Q3
1 quarter
|
|
5983
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$40.2M
| $23.3K | ﹤0.01% |
+38
| New | +$20K |
2024 Q4
0 quarters
|
|
5984
BlackRock MuniHoldings California Quality Fund
MUC
$920M
| $22.9K | ﹤0.01% |
2,150
| – | – |
2024 Q3
1 quarter
|
|
5985
Global X Variable Rate Preferred ETF
PFFV
$319M
| $22.8K | ﹤0.01% |
966
-42,362
| -98% | -$1.02M |
2024 Q3
1 quarter
|
|
5986
AC Immune
ACIU
$279M
| $22.7K | ﹤0.01% |
8,424
-2,272
| -21% | -$7.1K |
2020 Q4
16 quarters
|
|
5987
Invesco Municipal Trust
VKQ
$470M
| $22.6K | ﹤0.01% |
2,302
| – | – |
2024 Q1
3 quarters
|
|
5988
CALL
Fulcrum Therapeutics
FULC
$281M
| $22.6K | ﹤0.01% |
4,800
| – | – |
2024 Q2
2 quarters
|
|
5989
CALL
Cencora
COR
$59.1B
| $22.5K | ﹤0.01% |
100
-40,000
| -100% | -$9.41M |
2024 Q3
1 quarter
|
|
|
GRRR
5990
Gorilla Technology Group
GRRR
$374M
| $22.4K | ﹤0.01% |
1,240
| – | – |
2023 Q3
5 quarters
|
|
5991
ProShares UltraShort Russell2000
TWM
$60M
| $22.2K | ﹤0.01% |
+500
| New | +$21.4K |
2023 Q4
4 quarters
|
|
5992
Finward Bancorp
FNWD
$181M
| $22.2K | ﹤0.01% |
+788
| New | +$24.4K |
2024 Q4
0 quarters
|
|
5993
Inovio Pharmaceuticals
INO
$125M
| $21.9K | ﹤0.01% |
11,944
+190
| +2% | +$841 |
2014 Q3
41 quarters
|
|
5994
Invesco S&P 500 BuyWrite ETF
PBP
$391M
| $21.7K | ﹤0.01% |
922
-55
| -6% | -$1.27K |
2023 Q1
7 quarters
|
|
|
BRFS
5995
DELISTED
BRF SA
BRFS
| $21.6K | ﹤0.01% |
5,297
-72,121
| -93% | -$313K |
2022 Q2
10 quarters
|
|
5996
BNY Mellon International Equity ETF
BKIE
$1.3B
| $21.5K | ﹤0.01% |
888
| – | – |
2024 Q2
2 quarters
|
|
|
AMRN
5997
Amarin Corp
AMRN
$269M
| $21.5K | ﹤0.01% |
2,212
-462
| -17% | -$4.95K |
2016 Q3
33 quarters
|
|
5998
Simplify Affinity World Leaders Equity ETF
WLDR
$143M
| $21.3K | ﹤0.01% |
+719
| New | +$23.8K |
2024 Q4
0 quarters
|
|
5999
Northern Trust STOXX US ESG Select ETF
ESG
$135M
| $21.2K | ﹤0.01% |
154
| – | – |
2023 Q3
5 quarters
|
|
6000
iShares USD Green Bond ETF
BGRN
$496M
| $21.1K | ﹤0.01% |
+452
| New | +$21.4K |
2024 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.